DAWN MALCOM: Open Payments
NPI 1215439690 · BOGALUSA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 10 payments from 5 companies in 2025. Trend: 2023 $93 · 2024 $180 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $188 |
| Dexcom, Inc. | 2 | $36 |
| Novo Nordisk Inc | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: BREZTRI, Dexcom G6 Transmitter, Ozempic, UBRELVY, JARDIANCE, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
